Jane Street
HRMY icon

Jane Street’s Harmony Biosciences HRMY Stock Holding History

Jane Street’s Portfolio HRMY Stock Details HRMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.78M Sell
48,800
-35,000
-42% -$1.1M ﹤0.01% 5400
2026
Q1 		$2.35M Buy
83,800
+29,900
+55% +$980K ﹤0.01% 4787
2025
Q4 		$2.02M Buy
53,900
+1,900
+4% +$62.5K ﹤0.01% 4789
2025
Q3 		$1.43M Buy
52,000
+7,400
+17% +$255K ﹤0.01% 5559
2025
Q2 		$1.41M Buy
44,600
+37,100
+495% +$1.19M ﹤0.01% 4989
2025
Q1 		$249K Buy
+7,500
New +$269K ﹤0.01% 8116
2024
Q4 		– Sell
-5,100
Closed -$204K – 9901
2024
Q3 		$204K Buy
+5,100
New +$179K ﹤0.01% 8621
2024
Q1 		– Sell
-25,100
Closed -$811K – 9572
2023
Q4 		$811K Buy
+25,100
New +$701K ﹤0.01% 5947
2023
Q2 		– Sell
-39,400
Closed -$1.29M – 9061
2023
Q1 		$1.29M Buy
+39,400
New +$1.79M ﹤0.01% 4557

Other funds holding HRMY

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
LSV Asset Management
LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Jane Street's HRMY Position: Q2 2026 in Review

Jane Street sold out of Harmony Biosciences (HRMY) in Q2 2026, closing a stake of 9,993 shares — an estimated $315K sold.

Jane Street first reported a position in HRMY in Q1 2022 and held it in 14 quarters. The position peaked at $8.29M in Q4 2025. 327 funds tracked by Wall St. Rank hold HRMY as of Q2 2026.

  • Jane Street reported no remaining Harmony Biosciences position as of Q2 2026 after selling out during the quarter.
  • Jane Street sold 9,993 Harmony Biosciences shares in Q2 2026, an estimated $315K.
  • Jane Street first reported a position in Harmony Biosciences in Q1 2022 and held it in 14 quarters.
  • Jane Street's Harmony Biosciences position peaked at $8.29M in Q4 2025.
  • 327 funds tracked by Wall St. Rank held Harmony Biosciences as of Q2 2026.

Based on Jane Street's 13F filing for Q2 2026, filed 14 Aug 2026.